can mrcp replace ercp?kjpbt.org/upload/pdf/kpba-8-1-67.pdf · 2015-06-28 · 임 재훈 can mrcp...
TRANSCRIPT
2003년도 대한쉐담도연구회 학술대회 口 Recent Hot Issues (1) 口
Can MRCP Replace ERCP?
성균관의대 삼성서울병원 영상의학과
임
Summary
Magnetic resonance cholangiopancreatography (M
RCP) has replaced direct cholangiography and pan
creatography in many instances. lts complete non
invasiveness and flexibility are less onerous for pa
tients. For the use of screening as well as scrutiny,
MRCP has played an important role in diagnosing
various pathologies in this field. The usefulness of
MRCP is not limited to anatomical evaluations; it can
also yield physiologic and functional information
From a cost-performance basis, MRCP is undoubtedly
superior to direct methods. Coupled with a cutting
edge MR system, MRCP has the potential to limit the
use 0 invasive transpapi1lary and percutaneous methods
merely to interventional purposes. ln the near future,
the emergence of interventional MR scanners wi1l
make MRCP even more competitive, and the replace
ment wi1l be accelerated.
Introduction
In the field of abdominal imaging, magnetic resonance
cholangiopancreatography (MRCP) has been a great deal
of success in the past 5 years. Although 이rect
cholangiography and pancreatography are generally safe,
reliable, and widely available, these methods are
significantly operator-dependent, and they have the
potential to create significant complications, inc1uding
재
67
훈
acute pancreatitis, infection, hemorrhage, gastrointe
stinal perforation, and adverse reactions to contrast
media or premedications. The cost of endoscopic
retrograde cholanpancreatography (E RCP) is higher
than that of MRCP. MRCP has contributed to the
diminution of major and minor complications by
limiting the indications of direct cholangiography and
pancreatography. The implementations of many se
quence options and hardware refinements have made
MRCP one of the most robust imaging methods
Consequent recent success rates of diagnostic image
acquisition are reported to be increasingly high. Aside
from issues of safety and flexibility , MRCP may yield
more information about the pathologic and physio
logic conditions of the pancreatic duc t. Following is
a review of recent technologic achievements con
cerning MRCP and a description of the potential and
limitations of MRCP in comparison with those of
direct cholangiography and pancreatography.
Technical Considerations
Several technologic innovations have supported the
success of this technique. MRCP uses stationary water in
biliary and pancreatic secretions as an inσinsic contrast
media, thus imaging all fluidfilled structures in the upper
abdomen. The imaging strategy involves the acquisition
of a series of heavily T2-weighted images. Because
fluid-filled st ructures, biliary and pancreatic ducts, and
du여enum 뼈ve long 10ngitudinaI and σansverse relaxation
68 2003년도 대한춰l담도연구회 학술대회
times, they have hi양 si맑al intensity in T2-weighted
images. In these “hyd.ro맹phic images", everything 1∞k
black and white. Observers can evaluate the pancreatic and
biliary pathologies in이rectly using these “ all-or-nothing
images". To enhance the clarity of reconstructed images,
several postpr'α:essing tec뼈ques are sometimes r여비red.
뼈처mum intensity projection (MlP) algorithm makes a
thre엉imensional projection overview of the biliary and
pancreatic duct possible from any arbitrary view.
Multiplanar reforrnatting α1PR) allows the 뻐alysis of
arbitrary sections through inteπ:>O!ation
Secretin Administration
Secretin increases the secretion of bicarbonate by the
duct cells of the pancreas and bili앙y tract. Because
secretin causes marked secretion of an alkaline pancreatic
juice via the MPD, it can improve its delineation. The
initial effect of secretin is to contract Oddi ’s sphincter
Because the output of pancreatic juice is increased, the
occlusion of the outflow σact consequent1y elevates the
intraductal pr,않sure of MPD and results in the dilation of
MPD. Several minutes after aφ띠피sσations, Oddi ’s
sphincter begins to relax, and then the pancreatic juice
empties into the duodenum, which results in the deflation
of the MPD. All the proc않ses occur within 10 minutes,
which means that the imaging window for the dilated
MPD is quite linùted. If one uses secretin to estimate the
MPD dilation, MRCP with g∞d temporal resolution is
essential.
Cases Involving Failure to Cannulate or Fill
the Pancreatic or Biliary Ducts
Generally, MRCP plays an important role as a
substitute for direct cholangiography or pancreato
graphy when direct methods fai l. The widely rec
ognized success rate of ERCP (approximately 90%)
appears to be high, but the rate does not include
patients declined for relative contraindications such as
acute pancreatitis, age or infirmity, allergy to the
contrast media or premedications, prior upper gas
trointestinal surgery, gastroduodenal obstruction, or
pancreaticojejunostomy with Roux-en-Y modification.
In the cases with congenital anomalies or surgical
alterations of the upper gastrointestinal tract, the
success rate is lower. MRCP delineation of the
pancreaticobiliary system is not hampered by these
factors.
Biliary Obstructions
With transpapillary or percutaneous cholangio
graphy, the contrast media cannot pass beyond the
completely obstructed segment; thus, the accurate
length of the stenotic segment is not identified by
either ERCP or percutaneous transhepatic ch이an
giography (PTC) alone. To know the actual length of
the stenotic segment, contrast filling from both sides
(transpapillary and percutaneous) is sometimes need
ed. MRCP, on the other hand, can depict the stenosed
portion of the biliary tract in a single image. This
feature of MRCP is beneficial when planning inter
ventional procedures or radiotherapy for these patho
logies. The reported accuracy in detecting stenosed
segments is comparable to direct cholangiography
To differentiate malignant from benign lesions of
the biliary tree, general guidelines for interpretation of
cholangiography can also be applied to MRCP. Most
malignant 1esions cause an abrupt narrowing of the
bile duct, often with shouldered margins and mucosal
irregularities. Benign lesions, on the other hand, are
often smooth, gradually tapered stenosis. Nevertheless,
it should be remembered that a significant amount of
overlap does exist between the appearance of
malignant and benign lesions. In addition, the ability
of visualization of both the pancreatic and biliary
ducts in MRCP can often assist in diagnosis,
임 재훈 Can MRCP Replace ERCP? 69
particularly when adjacent strictures in both pancreatic documented ‘
and biliary ducts are seen. This is more suggestive of
a pancreatic carcinoma than of a biliary duct cancer.
Biliary Stones
The sensitivity of MRCP in detecting choledo
cholithiasis (81-95%) may be better than that of
direct cholangiography. Stones are shown as low
intensity filling defects within the bi \iary tract irre
spective of their calcifications. The finding is much
c\earer using MPR. These defects may not be apparent
on MIP images because of over1aying fluid. In our
own se디es, biliary stones as small as 3 mm were
correctly identified by MRCP. The detectability of the
bi \iary duct stones with MRCP is simply dependent
on their size. Hence, if compared with CT, MRCP
may be less sensitive to very small calculi with
calcification. As CT is so sensitive to calcified
materials, it can detect calcu\i as small as 1 mm, as
long as they are calcified.
Many investigators have found that, compared with
direct methods, spatial resolution of MRCP is poor.
However, MRCP enjoys superb contrast resolution. As
we see in the detectabi \ity of cho\edocholithiasis,
MRCP can often detect smaller calcu\i than direct
methods can. Further technologic achievements, may
improve the spatial resolution, but the practical and
reasonable spatial resolution required for accurate
diagnosis should be determined.
MRCP is reported to be able to detect hepato
\ithiasis in the se!ected cases. However, there is an
ambiguity if eveη discontinuity of the nondilated
intrahepatic biliary duct seen on MRCP can be
correctly differentiated from small hepatoliths. Co
existing pneumobilia often seen in patients with prior
biliojejunostomy may also be problematic in the MR
diagnosis of biliary duct stones. The role of MRCP
in diagnosing hepatolithaisis remains to be
Chronic Pancreatitis
In the initial workup of patients with chronic
pancreatitis, MRCP is useful in depicting dilated or
narrowed segments of the MPD, which are the
hallmarks of chronic pancreatitis. Pancreatic ca1cu\i
and plaques are detectable as round filling defects
within the MPD. Deviation and/or dilation of the
bi\iary duct is also seen when affected. Side branches
of the MPD, however, are not usually depicted unless
dilated. The reported sensitivity was 87% to 100% for
dilation, 75% for narrowing, and 100% for filling
defects. Because stenotic portions may be recon
structed or resected surgically, detection of the
stenosis is an important role of MRCP.
Nonspecific ductal dilation may be found in elder1y
patients and should be differentiated from charac
teristics of chronic pancreatitis. Because such patients
are often asymptomatic, correlation with laboratory
data and patients ’ symptoms and history is essential.
To rule out pathologic conditions, determination with
noninvasive MRCP is the first choice.
Desmoplastic ductal cancers and chronic fibrosing
focal pancreatitis are often difficult to differentiate. In
selected cases, ERCP has been said to be helpful in
differentiating masses created by focal pancreatitis
from adenocarcinoma. A dilated duct may be seen
within a mass produced by focal pancreatitis but not
within a ductal carcinoma. ERCP often fails to fill the
entire segment of the affected MPD and the side
branches because of occ\usion of ducts involved
within the mass. MRCP, on the other hand, can depict
both the narrowed MPD and isolated dilated side
branches within the mass. MRCP, .on the other hand,
can depict both the narrowed MPD and isolated
dilated side branches within the mass, which may
suggest the benign nature of the mass. This finding
70 2003년도 대한춰l담도연구회 학술대회
is characteristic of, but not specific to, chronic
pancreatitis. With the use of MRCP, duct penetration
is found within the mass in five of six cases (83%)
with mass-forming pancreatitis, but the imaging fea
ture was also found in 2 of 20 (10%) cases with
malignant solid tumors.
Acute Pancreatitis
Severe acute pancreatitis is sometimes accom
panied by complications, such as pancreatic fluid
collections, extrapancreatic fluid collections, or
pancreatic pseudocysts. The surgical treatment of
pancreatic pseudocysts inc1udes excision or intemal or
extemal drainage. The success of surgical treatment
depends on correct localization and depiction of the
morphology as well as the status of the pancreatic
ducts. MRCP demonstrates the anatomy of the MPD
and biliary tract in relation to the location of
pseudocysts. ERCP can readily show the site of
extravasation in pancreatic fistulas, localize the source
of pancreatic ascites, and demonstrate the continuity
of abscesses or pseudocysts with the ductal system
However, contrast media injection into a cyst may
cause infection that results in pancreatic or peri
pancreatic abscesses. Our limited experience in acute
pancreatitis suggests that MRCP is safe and helpful
in providing information about 1) the presence or ab
sence of the ductal distention, 2) disruption, 3)
leakage of the pancreatic duct, and 4) intraductal
lesions that might raise the intraductal pressure and
create a predisposition to pseudocyst formation. The
detection or pseudocysts using MRCP is straight
forward, and localization, size, shape, and number are
also adequately shown through its use. The
information is important because it determines the
severity of acute pancreatitis and influences the choice
of treatment.
Pancreatic Cancer
ERCP has been used primarily as an adjunctive
method for investigating suspected pancreatic carci
noma in patients with ambiguous CT findings
Because symptomatic pancreatic cancer usually in
volves the MPD, obstruction of the MPD is the most
common finding in carcinoma. The ducts downstream
to the occ1usion are basically normal in carcinoma, whereas changes reflecting pancreatitis are usually
present in the ducts upstream to the obstruction. The
pattem of obstruction is usually irregular, nodular,
rat-tailed, or eccentric in carcinoma and smooth or
blunt in pancreatitis. MRCP can depict the narrowed
or amputated MPD as well as dilated upstream ducts
quite wel l. Ampullary cancer is easily detected by
diffuse and smooth dilation of the biliary duct and the
pancreatic duc t. With adequate fluid filling, the tumor
is often outlined within the duodenum around the
papilla of Vater. Detection of early ductal cancer,
however, is extremely difficult. As small ductal cancer
often causes very subtle ductal abnormalities in the
MPD or side branches, such lesions are diffic비t to
identify through the use of MRCP. Although not
frequently seen, ERCP could detect small peripheral
carcinomas that focally obliterate small lateral side
branches or cause a focal defect in parenchymal
acinarization. Such subtle findings, for example, might
not be seen by current MRCP. However, small cancer
detection might not be a role of MRCP. Because MR
examination can offer parenchymal contrast,
combination of high-resolution, fat-saturated Tl con
trast images and dynamic contrast MR images can
detect smaller tumors within the pancreas. The
information is superior or equivalent to that derived
from ERCP with parenchymal acinarization.
Intraductal Papillary Mucinous Tumor
임재훈 Can MRCP Replace ERCP? 71
duodenal gas may migrate into the pancreatic duc t.
The presence of air bubbles within the dilated main
pancreatic duct may mislead observers to make a
Endoscopic inspection typically reveals an enlarged false-positive diagnosis of papillary tumor growth
papilla with mucus flowing from a patulous orifice
On ERCP, diffuse or segmental dilation of the MPD Cost-Effectiveness
or cystic dilations of the side branches, sometimes
grape-like, are common. Fungating lesions are One of the most notable features of MRI is that MR
sometimes detected as filling defects in ERCP after can offer several different tests as an allin-one
successful drainage of the mucin. Because ERCP can package. An MR examination includes MRCP, MR
prove the existence of communicating channels angiography, perfusion imaging, and of course, ordi-
btween the cystic lesions and the MPD, ERCP is said nary cross-sectional MRI based on Tl- or T2-
to be the most reliable method in diagnosing this weighted irnages with or without fat saturation.
neoplasm. However, it is also true that the mucin Interventional procedures using MR imagers are being
often prevents the dilated side branches from contrast implemented, as wel l. When all of these individual
filling. On the other hand, MRCP detection of tests are optimized, MRI may obviate the additional
communicating channels is not affected by mucin, use of other modalities such as direct cholan-
thus more accurate diagnosis is possible in cases with giography, pancreatography, angiography, or contrast-
dilated communicating channels. In cases with pat- enhanced CT
ulous orifice of the enlarged ampulla of Vater,